What's new ? - 2018

What's new ? - 2018

FDA: 5-Year plan for supporting antimicrobial stewardship in veterinary settings

14 September, 2018

The U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) unveiled its five-year action plan for supporting antimicrobial stewardship in veterinary settings. This plan builds upon the important steps CVM has taken to eliminate production uses of medically important antimicrobials (i.e., antimicrobials important for treating human disease) and to bring all remaining therapeutic uses of these drugs under the oversight of licensed veterinarians. It also supports the judicious use of antimicrobials in food-producing animals and is driven by the concept that medically important antimicrobial drugs should only be used in animals when necessary for the treatment, control or prevention of specific diseases.
While CVM has implemented many important steps to support stewardship of medically important antimicrobials in animals, additional steps are needed. The key goals and objectives that will be focus during fiscal years 2019 – 2023 are:
1. Align antimicrobial drug product use with the principles of antimicrobial stewardship
2. Foster stewardship of antimicrobials in veterinary settings
3. Enhance monitoring of antimicrobial resistance and antimicrobial drug use in animals
CVM plans to initiate the actions in phases over the next five fiscal years. This phased approach will allow for adjustments based on critical, science-based analysis, public health impact, and feedback from stakeholders.